何佳彧, 梁菊, 宣茂松, 吴文澜. 提高多肽体内稳定性的有效策略J. 药学学报, 2020,55(1): 25-32. doi: 10.16438/j.0513-4870.2019-0696
引用本文: 何佳彧, 梁菊, 宣茂松, 吴文澜. 提高多肽体内稳定性的有效策略J. 药学学报, 2020,55(1): 25-32. doi: 10.16438/j.0513-4870.2019-0696
HE Jia-yu, LIANG Ju, XUAN Mao-song, WU Wen-lan. Effective strategies for improving the stability of peptides in vivoJ. Acta Pharmaceutica Sinica, 2020,55(1): 25-32. doi: 10.16438/j.0513-4870.2019-0696
Citation: HE Jia-yu, LIANG Ju, XUAN Mao-song, WU Wen-lan. Effective strategies for improving the stability of peptides in vivoJ. Acta Pharmaceutica Sinica, 2020,55(1): 25-32. doi: 10.16438/j.0513-4870.2019-0696

提高多肽体内稳定性的有效策略

Effective strategies for improving the stability of peptides in vivo

  • 摘要: 多肽在基因/药物递送和疾病靶向治疗领域应用广泛,但天然多肽在体内容易被蛋白酶水解,半衰期短。很多研究致力于对多肽结构进行一定程度的改造或修饰,希望能够提高多肽的递送和治疗效果。本文总结了近几年文献报道中关于多肽稳定性的研究报道,根据多肽结构改造方式的不同进行文献分类,介绍了各种结构改造和修饰方法对提高多肽的体内循环稳定性和半衰期的作用,有针对性地分析了影响体内多肽稳定性的相关因素,以期为多肽的进一步体内研究和应用提供数据和理论参考。

     

    Abstract: Peptides have been extensively used in the fields of gene/drug delivery and disease targeting therapy. However, natural peptides are sensitive to protease digestion with short circulatory half-lives in vivo. Many studies on structural modifications of peptides have been reported to improve the delivery or therapeutic effect. In this review we focus on the recent literature on peptide stability in accordance with different structural modifications and summarize the methods and influential factors that are involved in the improvement of stability and half-life in vivo. This review will provide the scientific basis and theoretical references for further investigations and applications in vivo.

     

/

返回文章
返回